Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2518)
All Articles published online
|
Feb 21, 2007 (publication date) through Nov 8, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Venkataranganna M, Rafiq M, Gopumadhavan S, Peer G, Babu U, Mitra S. NCB-02 (standardized Curcumin preparation) protects dinitrochlorobenzene-induced colitis through down-regulation of NFκ-B and iNOS. World J Gastroenterol 2007; 13(7): 1103-1107 [PMID: 17373747 DOI: 10.3748/wjg.v13.i7.1103] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i7/1103.htm |
| Number | Citing Articles |
| 1 |
C. B. Larmonier, J. K. Uno, Kang-Moon Lee, T. Karrasch, D. Laubitz, R. Thurston, M. T. Midura-Kiela, F. K. Ghishan, R. B. Sartor, C. Jobin, P. R. Kiela. Limited effects of dietary curcumin on Th-1 driven colitis in IL-10 deficient mice suggest an IL-10-dependent mechanism of protection. American Journal of Physiology-Gastrointestinal and Liver Physiology 2008; 295(5): G1079 doi: 10.1152/ajpgi.90365.2008
|
| 2 |
Alon Lang, Nir Salomon, Justin C.Y. Wu, Uri Kopylov, Adi Lahat, Ofir Har-Noy, Jessica Y.L. Ching, Pui Kuan Cheong, Benjamin Avidan, Dorit Gamus, Ioannis Kaimakliotis, Rami Eliakim, Siew C. Ng, Shomron Ben-Horin. Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial. Clinical Gastroenterology and Hepatology 2015; 13(8): 1444 doi: 10.1016/j.cgh.2015.02.019
|
| 3 |
Asmaa S. Lubbad, Mabayoje A. Oriowo, Islam Khan. Curcumin reverses attenuated carbachol-induced contraction of the colon in a rat model of colitis. Scandinavian Journal of Gastroenterology 2009; 44(2): 187 doi: 10.1080/00365520802449302
|
| 4 |
FardousSoror Karawya, El SayedAly Mohamed Metwally. Effects of jujube fruit extract on acetic acid-induced colitis in adult male rats. Journal of Experimental and Clinical Anatomy 2016; 15(1): 19 doi: 10.4103/1596-2393.190828
|
| 5 |
Alyssa M. Parian, Gerard E. Mullin, Jost Langhorst, Amy C. Brown. Integrative Medicine. 2018; : 501 doi: 10.1016/B978-0-323-35868-2.00050-5
|
| 6 |
Su Xu, Zhao‑Xiu Xu, Shuai Yan, Jin Le, Hao Chen, Lan Ming, Shu‑Guang Xu, Tao Lin. Curcumin suppresses intestinal microvascular endothelial cells invasion and angiogenesis induced by activated platelets. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.7662
|
| 7 |
Manjeshwar Shrinath Baliga, Arpit Saxena, Kamaljeet Kaur, Faizan Kalekhan, Amala Chacko, Ponemone Venkatesh, Raja Fayad. Polyphenols in Human Health and Disease. 2014; : 655 doi: 10.1016/B978-0-12-398456-2.00050-5
|
| 8 |
Amir Rashidian, Hedieh Keshavarz-Bahaghighat, Alireza Abdollahi, Mohsen Chamanara, Hedyeh Faghir-Ghanesefat, Mohsen Hoseini-Ahmadabadi, Ahmad Reza Dehpour. Agmatine ameliorates acetic acid-induced colitis in rats: involvement of nitrergic system. Immunopharmacology and Immunotoxicology 2019; 41(2): 242 doi: 10.1080/08923973.2019.1578973
|
| 9 |
P. Martínez-Moya, M. Ortega-González, R. González, A. Anzola, B. Ocón, C. Hernández-Chirlaque, R. López-Posadas, M.D. Suárez, A. Zarzuelo, O. Martínez-Augustin, F. Sánchez de Medina. Exogenous alkaline phosphatase treatment complements endogenous enzyme protection in colonic inflammation and reduces bacterial translocation in rats. Pharmacological Research 2012; 66(2): 144 doi: 10.1016/j.phrs.2012.04.006
|
| 10 |
Ajaikumar B. Kunnumakkara, Sushovan Guha, Bharat B. Aggarwal. Curcumin and colorectal cancer: Add spice to your life. Current Colorectal Cancer Reports 2009; 5(1): 5 doi: 10.1007/s11888-009-0002-0
|
| 11 |
Mert Ilhan, Esra Küpeli Akkol, Hakkı Taştan, Fatma Tuğçe Gürağaç Dereli, Ibrahim Tümen. Efficacy of Pyrus elaeagnifolia subsp. elaeagnifolia in acetic acid–induced colitis model. Open Chemistry 2019; 17(1): 13 doi: 10.1515/chem-2019-0002
|
| 12 |
C. B. Larmonier, M. T. Midura-Kiela, R. Ramalingam, D. Laubitz, N. Janikashvili, N. Larmonier, F. K. Ghishan, P. R. Kiela. Modulation of neutrophil motility by curcumin. Inflammatory Bowel Diseases 2011; 17(2): 503 doi: 10.1002/ibd.21391
|
| 13 |
Bao‐Jian Guo, Zhao‐Xiang Bian, Hong‐Cong Qiu, Yi‐Tao Wang, Ying Wang. Biological and clinical implications of herbal medicine and natural products for the treatment of inflammatory bowel disease. Annals of the New York Academy of Sciences 2017; 1401(1): 37 doi: 10.1111/nyas.13414
|
| 14 |
Manasi Agrawal, Shitij Arora, Jianjun Li, Rabin Rahmani, Li Sun, Adam F. Steinlauf, Jeffrey I. Mechanick, Mone Zaidi. Bone, Inflammation, and Inflammatory Bowel Disease. Current Osteoporosis Reports 2011; 9(4): 251 doi: 10.1007/s11914-011-0077-9
|
| 15 |
Gunhyuk Park, Dal-Seok Oh, Mi Gi Lee, Chang Eon Lee, Yong-ung Kim. 6-Shogaol, an active compound of ginger, alleviates allergic dermatitis-like skin lesions via cytokine inhibition by activating the Nrf2 pathway. Toxicology and Applied Pharmacology 2016; 310: 51 doi: 10.1016/j.taap.2016.08.019
|
| 16 |
Farzaneh Fallahi, Sarina Borran, Milad Ashrafizadeh, Ali Zarrabi, Mohammad Hossein Pourhanifeh, Mahmood Khaksary Mahabady, Amirhossein Sahebkar, Hamed Mirzaei. Curcumin and inflammatory bowel diseases: From in vitro studies to clinical trials. Molecular Immunology 2021; 130: 20 doi: 10.1016/j.molimm.2020.11.016
|
| 17 |
Lin Cao, Dengyi Duan, Jing Peng, Ruinan Li, Qi Cao, Xinwen Li, Yunfei Guo, Jianmin Li, Kangkang Liu, Yiming Li, Wenyi Zhang, Shuang Liu, Xuening Zhang, Yang Zhao. Oral enzyme-responsive nanoprobes for targeted theranostics of inflammatory bowel disease. Journal of Nanobiotechnology 2024; 22(1) doi: 10.1186/s12951-024-02749-1
|
| 18 |
Arya V.S., Kanthlal S.K.. Phloretin Ameliorates Acetic Acid Induced Colitis Through Modulation of Immune and Inflammatory Reactions in Rats. Endocrine, Metabolic & Immune Disorders - Drug Targets 2021; 21(1): 163 doi: 10.2174/1871530320666200624120257
|
| 19 |
Pooja Mongia Raj, Rakesh Raj, Ankur Kaul, Anil K. Mishra, Alpana Ram. Biodistribution and targeting potential assessment of mucoadhesive chitosan nanoparticles designed for ulcerative colitis via scintigraphy. RSC Advances 2018; 8(37): 20809 doi: 10.1039/C8RA01898G
|
| 20 |
Conor Lahiff, Alan C. Moss. Curcumin for clinical and endoscopic remission in ulcerative colitis. Inflammatory Bowel Diseases 2011; 17(7): E66 doi: 10.1002/ibd.21710
|
| 21 |
Pascal Juillerat, Joshua R. Korzenik. Medical Therapy of Ulcerative Colitis. 2014; : 221 doi: 10.1007/978-1-4939-1677-1_19
|
| 22 |
Juan Manuel Sánchez‐Calvo, Isabel Villegas, Susana Sánchez‐Fidalgo, Laura Camacho‐Barquero, Elena Talero, Virginia Motilva, Catalina Alarcón de la Lastra. Protective effect of curcumin, a Curcuma longa constituent, in early colonic inflammation in rats. Drug Development Research 2009; 70(6): 425 doi: 10.1002/ddr.20319
|
| 23 |
Lucas Fornari Laurindo, Ana Rita de Oliveira dos Santos, Antonelly Cassio Alves de Carvalho, Marcelo Dib Bechara, Elen Landgraf Guiguer, Ricardo de Alvares Goulart, Renata Vargas Sinatora, Adriano Cressoni Araújo, Sandra Maria Barbalho. Phytochemicals and Regulation of NF-kB in Inflammatory Bowel Diseases: An Overview of In Vitro and In Vivo Effects. Metabolites 2023; 13(1): 96 doi: 10.3390/metabo13010096
|
| 24 |
Quanlai Zhao, Chen Liu, Xiang Shen, Liang Xiao, Hong Wang, Ping Liu, Lingting Wang, Hongguang Xu. Cytoprotective effects of myristicin against hypoxia-induced apoptosis and endoplasmic reticulum stress in rat dorsal root ganglion neurons. Molecular Medicine Reports 2017; 15(4): 2280 doi: 10.3892/mmr.2017.6258
|
| 25 |
Bernard Uzzan, Robert Benamouzig. Is Curcumin a Chemopreventive Agent for Colorectal Cancer?. Current Colorectal Cancer Reports 2016; 12(1): 35 doi: 10.1007/s11888-016-0307-8
|
| 26 |
Mit Joshi, Neetinkumar D. Reddy, Nitesh Kumar, Suhani Sumalatha, Mallikarjuna Rao Chamallamudi. Cinnamyl Sulfonamide Hydroxamate Derivatives Inhibited LPS-Stimulated NF-kB Expression in RAW 264.7 Cells In Vitro and Mitigated Experimental Colitis in Wistar Rats In Vivo. Current Pharmaceutical Design 2020; 26(38): 4934 doi: 10.2174/1381612826666200625101442
|
| 27 |
Phani Krishna Kondamudi, Hemalatha Kovelamudi, Geetha Mathew, Pawan G. Nayak, C. Mallikarjuna Rao, Rekha R. Shenoy. Modulatory effects of sesamol in dinitrochlorobenzene-induced inflammatory bowel disorder in albino rats. Pharmacological Reports 2013; 65(3): 658 doi: 10.1016/S1734-1140(13)71043-0
|
| 28 |
Katherine Z. Sanidad, Elvira Sukamtoh, Hang Xiao, David Julian McClements, Guodong Zhang. Curcumin: Recent Advances in the Development of Strategies to Improve Oral Bioavailability. Annual Review of Food Science and Technology 2019; 10(1): 597 doi: 10.1146/annurev-food-032818-121738
|
| 29 |
Masoud Nouri-Vaskeh, Hossein Afshan, Aida Malek Mahdavi, Leila Alizadeh, Xiude Fan, Mohammad Zarei. Curcumin ameliorates health-related quality of life in patients with liver cirrhosis: A randomized, double-blind placebo-controlled trial. Complementary Therapies in Medicine 2020; 49: 102351 doi: 10.1016/j.ctim.2020.102351
|
| 30 |
Arpit Saxena, Kamaljeet Kaur, Shweta Hegde, Faizan M. Kalekhan, Manjeshwar Shrinath Baliga, Raja Fayad. Dietary Agents and Phytochemicals in the Prevention and Treatment of Experimental Ulcerative Colitis. Journal of Traditional and Complementary Medicine 2014; 4(4): 203 doi: 10.4103/2225-4110.139111
|
| 31 |
Ajay Goel, Ajaikumar B. Kunnumakkara, Bharat B. Aggarwal. Curcumin as “Curecumin”: From kitchen to clinic. Biochemical Pharmacology 2008; 75(4): 787 doi: 10.1016/j.bcp.2007.08.016
|
| 32 |
Sudhina Sufina Nazar, Janeesh Plakkal Ayyappan. Mechanistic evaluation of myristicin on apoptosis and cell cycle regulation in breast cancer cells. Journal of Biochemical and Molecular Toxicology 2024; 38(6) doi: 10.1002/jbt.23740
|
| 33 |
Fan Cao, Jie Liu, Bing-Xian Sha, Hai-Feng Pan. Natural Products: Experimental Efficient Agents for Inflammatory Bowel Disease Therapy. Current Pharmaceutical Design 2020; 25(46): 4893 doi: 10.2174/1381612825666191216154224
|
| 34 |
Hossam M.M. Arafa, Ramadan A. Hemeida, Ali I.M. El-Bahrawy, Farid M.A. Hamada. Prophylactic role of curcumin in dextran sulfate sodium (DSS)-induced ulcerative colitis murine model. Food and Chemical Toxicology 2009; 47(6): 1311 doi: 10.1016/j.fct.2009.03.003
|
| 35 |
Adam S. Cheifetz, Robert Gianotti, Raphael Luber, Peter R. Gibson. Complementary and Alternative Medicines Used by Patients With Inflammatory Bowel Diseases. Gastroenterology 2017; 152(2): 415 doi: 10.1053/j.gastro.2016.10.004
|
| 36 |
María Gálvez-Llompart, María C. Recio, Ramón García-Domenech. Topological virtual screening: a way to find new compounds active in ulcerative colitis by inhibiting NF-κB. Molecular Diversity 2011; 15(4): 917 doi: 10.1007/s11030-011-9323-4
|
| 37 |
Francesca Algieri, Alba Rodriguez-Nogales, M. Elena Rodriguez-Cabezas, Severiano Risco, M. Angeles Ocete, Julio Galvez, Francesco Maione. Botanical Drugs as an Emerging Strategy in Inflammatory Bowel Disease: A Review. Mediators of Inflammation 2015; 2015(1) doi: 10.1155/2015/179616
|
| 38 |
Kathryn Burge, Aarthi Gunasekaran, Jeffrey Eckert, Hala Chaaban. Curcumin and Intestinal Inflammatory Diseases: Molecular Mechanisms of Protection. International Journal of Molecular Sciences 2019; 20(8): 1912 doi: 10.3390/ijms20081912
|
| 39 |
Shiran Shapira, Ari Leshno, Daniel Katz, Nitsan Maharshak, Gil Hevroni, Maayan Jean-David, Sarah Kraus, Lior Galazan, Ilan Aroch, Dina Kazanov, Aharon Hallack, Stewart Becker, Mark Umanski, Menachem Moshkowitz, Iris Dotan, Nadir Arber. Of mice and men: a novel dietary supplement for the treatment of ulcerative colitis. Therapeutic Advances in Gastroenterology 2018; 11 doi: 10.1177/1756283X17741864
|
| 40 |
Adhimoolam Karthikeyan, Kim Na Young, Mohammad Moniruzzaman, Anteneh Marelign Beyene, Kyoungtag Do, Senthil Kalaiselvi, Taesun Min. Curcumin and Its Modified Formulations on Inflammatory Bowel Disease (IBD): The Story So Far and Future Outlook. Pharmaceutics 2021; 13(4): 484 doi: 10.3390/pharmaceutics13040484
|
| 41 |
MARLA DE CERQUEIRA ALVES, MONISE OLIVEIRA SANTOS, NASSIB BEZERRA BUENO, ORLANDO ROBERTO PIMENTEL DE ARA贘O, MAR蚅IA OLIVEIRA FONSECA GOULART, FABIANA ANDR葾 MOURA. Efficacy of oral consumption of curcumin/ for symptom improvement in inflammatory bowel disease: A systematic review of animal models and a meta-analysis of randomized clinical trials. BIOCELL 2022; 46(9): 2015 doi: 10.32604/biocell.2022.020407
|
| 42 |
Vittorio Calabrese, Carolin Cornelius, Cesare Mancuso, Giovanni Pennisi, Stella Calafato, Francesco Bellia, Timothy E. Bates, Anna Maria Giuffrida Stella, Tony Schapira, Albena T. Dinkova Kostova, Enrico Rizzarelli. Cellular Stress Response: A Novel Target for Chemoprevention and Nutritional Neuroprotection in Aging, Neurodegenerative Disorders and Longevity. Neurochemical Research 2008; 33(12): 2444 doi: 10.1007/s11064-008-9775-9
|
| 43 |
Kinnri Jain, Devinder K. Dhawan. Regulation of Biokinetics of 65Zn by Curcumin and Zinc in Experimentally Induced Colon Carcinogenesis in Rats. Cancer Biotherapy and Radiopharmaceuticals 2014; 29(8): 310 doi: 10.1089/cbr.2014.1670
|
| 44 |
Bharat B. Aggarwal, Kuzhuvelil B. Harikumar. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. The International Journal of Biochemistry & Cell Biology 2009; 41(1): 40 doi: 10.1016/j.biocel.2008.06.010
|
| 45 |
D. Soni, B. Salh. A Neutraceutical by Design: The Clinical Application of Curcumin in Colonic Inflammation and Cancer. Scientifica 2012; 2012: 1 doi: 10.6064/2012/757890
|
| 46 |
Jenny Epstein, Ian R. Sanderson, Thomas T. MacDonald. Curcumin as a therapeutic agent: the evidence fromin vitro, animal and human studies. British Journal of Nutrition 2010; 103(11): 1545 doi: 10.1017/S0007114509993667
|
| 47 |
Sigrid A Rajasekaran. Therapeutic potential of curcumin in gastrointestinal diseases. World Journal of Gastrointestinal Pathophysiology 2011; 2(1): 1-14 doi: 10.4291/wjgp.v2.i1.1
|
| 48 |
Elroy Saldanha, Arpit Saxena, Kamaljit Kaur, Faizan Kalekhan, Ponemone Venkatesh, Raja Fayad, Suresh Rao, Thomas George, Manjeshwar Shrinath Baliga. Dietary Interventions in Gastrointestinal Diseases. 2019; : 277 doi: 10.1016/B978-0-12-814468-8.00023-5
|
| 49 |
Ajaikumar B. Kunnumakkara, Preetha Anand, Bharat B. Aggarwal. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Letters 2008; 269(2): 199 doi: 10.1016/j.canlet.2008.03.009
|
| 50 |
Shanshan Tie, Yannan Chen, Mingqian Tan. An evaluation of animal models for using bioactive compounds in the treatment of inflammatory bowel disease. Food Frontiers 2024; 5(2): 474 doi: 10.1002/fft2.360
|
| 51 |
Vittorio Calabrese, Timothy E. Bates, Cesare Mancuso, Carolin Cornelius, Bernardo Ventimiglia, Maria Teresa Cambria, Laura Di Renzo, Antonino De Lorenzo, Albena T. Dinkova‐Kostova. Curcumin and the cellular stress response in free radical‐related diseases. Molecular Nutrition & Food Research 2008; 52(9): 1062 doi: 10.1002/mnfr.200700316
|
| 52 |
Manjeshwar Shrinath Baliga, Nandhini Joseph, Marikunte V. Venkataranganna, Arpit Saxena, Venkatesh Ponemone, Raja Fayad. Curcumin, an active component of turmeric in the prevention and treatment of ulcerative colitis: preclinical and clinical observations. Food & Function 2012; 3(11): 1109 doi: 10.1039/c2fo30097d
|
| 53 |
Bharat B Aggarwal, Subash C Gupta, Bokyung Sung. Curcumin: an orally bioavailable blocker of TNF and other pro‐inflammatory biomarkers. British Journal of Pharmacology 2013; 169(8): 1672 doi: 10.1111/bph.12131
|